Related Experiment Video
Updated: Jan 11, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Genetic and metabolomic pathways linking frailty, chronic kidney disease, and kidney failure: a Mendelian
Yiding Chen1,2,3, Kun Wang1,2,3,4, Xiangyu Zhang1,2,3,5
1Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, P. R. China.
Abstract:
Global population aging highlights frailty as a critical health concern, yet its genetic basis remains poorly understood. We employed Mendelian randomization (MR) and National Health and Nutrition Examination Survey (NHANES) to examine causal relationships between frailty index (FI) and 36 urological diseases, investigating shared genetic mechanisms. The FI was calculated using genome-wide association data, and bidirectional MR analysis with multiple statistical methods was applied to investigate causal links between FI and 36 urological diseases. Complementary observational analyses using NHANES and generalized summary MR validation were conducted, followed by genetic correlation assessments, genome annotation, and metabolomic explorations to identify mediating pathways. MR analysis identified a significant causal association between FI and renal tubule-interstitial disease, chronic kidney diseases (CKDs), diabetes with renal complications, renal failure, and acute kidney injury. Reverse MR analysis indicated a bidirectional causal relationship between FI and acute renal failure, as well as CKD and type 1 diabetic kidney disease. NHANES data confirmed FI as an independent risk factor for CKD and renal failure. Genetic linkage analyses identified strong regional correlations between FI and CKD/renal failure within the chromosome 6 locus (31,571,218-32,682,664). Genome-wide analyses uncovered 103 novel single-nucleotide polymorphism with pleiotropic effects on the frailty-urinary disease relationship. Mediation analyses implicated the complement pathway (C2), SLITRK1, and 4-methylhexanoylglutamine as putative mediators of FI effects on CKD and kidney failure. This study elucidates the bidirectional causal relationship between frailty and CKD, while identifying novel genetic variants and metabolic pathways. These findings provide a molecular basis for developing personalized therapeutic strategies targeting both frailty and urological disorders.
More Related Videos
11:47Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Related Concept Videos
Chronic Kidney Disease I: Introduction
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology